American Association for the Advancement of Science, Science Immunology, 64(6), 2021
DOI: 10.1126/sciimmunol.abh0707
Full text: Unavailable
Type 2 immune development depends on MARCH1-mediated turnover of MHCII and CD86 by lymph node–resident dendritic cells.